REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >

BNSSG Paediatric Joint Formulary

2.10 Vascular disease

Last edited: 31-01-2024

First line drugs Second line drugs Specialist drugs Secondary care drugs

2.10 Vascular disease

Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility

Peripheral Vascular Disease

 

5HT2 Receptor Antagonists

Naftidrofuryl oxalate (TLS Blue)

  • NICE TA223 For the treatment of intermittent claudication in people with peripheral arterial disease